Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 87 Carcinoma, Non-Small-Cell Lung 76 Breast Neoplasms 73 Recurrence 65 Colorectal Neoplasms 63 Pancreatic Neoplasms 60 Melanoma 58 Advanced Solid Tumor 57 Multiple Myeloma 56 Carcinoma, Hepatocellular 56 Lymphoma 53 Leukemia, Myeloid, Acute 53 Advanced Solid Tumors 53 Neoplasm Metastasis 51 Stomach Neoplasms 47 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Lymphoma, B-Cell 40 Solid Tumor 39 Lymphoma, Non-Hodgkin 39 Ovarian Neoplasms 38 Lung Neoplasms 36 Glioblastoma 35 Prostatic Neoplasms 34 Leukemia 28 Head and Neck Neoplasms 27 Leukemia, Lymphocytic, Chronic, B-Cell 26 Uterine Cervical Neoplasms 25 Burkitt Lymphoma 24 Esophageal Neoplasms 23 Urinary Bladder Neoplasms 20

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Unknown × Platinum-resistant Ovarian Cancer × Clear all

NCT04678102 2023-06-26

CREATIVE

Seoul National University Hospital

Phase 1 Unknown

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡